Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Friedland

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|April 13, 2011
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumoniaDouglas R Rank, H David Friedland, Joseph B Laudano
Hospital Practice (1995)|September 26, 2014
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patientsGeorge Udeani, John Evans, Phillip Cole, et al.
Expert Review of Clinical Pharmacology|December 4, 2014
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiencyChristy Maggiore, Timothy Pasquale, Phillip Cole, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2013
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspectiveXingyue Huang, Eric Beresford, Thomas Lodise, et al.
Hospital Practice (1995)|May 10, 2015
Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumoniaKeith S Kaye, George Udeani, Phillip Cole, et al.
Postgraduate Medicine|October 9, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patientsJohn D Evans, George Udeani, Phillip Cole, et al.
International Journal of Antimicrobial Agents|June 16, 2009
Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation modelsEvelina Rubinchik, Dominique Dugourd, Teresa Algara, et al.
Computer Methods and Programs in Biomedicine Update|May 6, 2026
Interpretable machine learning text classification for clinical computed tomography reports - a case study of temporal bone fractureTong Ling, Luo Jake, Jazzmyne Adams, et al.
Journal of Chemotherapy (Florence, Italy)|October 3, 2013
Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experiencePaul D Santos, Amanda Davis, Alena Jandourek, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 22, 2025
Correlation Between Life Stress and Tinnitus SeverityBeatrice Mumm, David Friedland, Jazzmyne Adams, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|April 13, 2011
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumoniaDouglas R Rank, H David Friedland, Joseph B Laudano
Hospital Practice (1995)|September 26, 2014
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patientsGeorge Udeani, John Evans, Phillip Cole, et al.
Expert Review of Clinical Pharmacology|December 4, 2014
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiencyChristy Maggiore, Timothy Pasquale, Phillip Cole, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2013
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspectiveXingyue Huang, Eric Beresford, Thomas Lodise, et al.
Hospital Practice (1995)|May 10, 2015
Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumoniaKeith S Kaye, George Udeani, Phillip Cole, et al.
Postgraduate Medicine|October 9, 2014
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patientsJohn D Evans, George Udeani, Phillip Cole, et al.
International Journal of Antimicrobial Agents|June 16, 2009
Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation modelsEvelina Rubinchik, Dominique Dugourd, Teresa Algara, et al.
Computer Methods and Programs in Biomedicine Update|May 6, 2026
Interpretable machine learning text classification for clinical computed tomography reports - a case study of temporal bone fractureTong Ling, Luo Jake, Jazzmyne Adams, et al.
Journal of Chemotherapy (Florence, Italy)|October 3, 2013
Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experiencePaul D Santos, Amanda Davis, Alena Jandourek, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 22, 2025
Correlation Between Life Stress and Tinnitus SeverityBeatrice Mumm, David Friedland, Jazzmyne Adams, et al.
Pageof 6